Indication
B-Cell Lymphoblastic Lymphoma
1 clinical trial
8 products
2 drugs
Clinical trial
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)Status: Active (not recruiting), Estimated PCD: 2019-03-31
Drug
cyclophosphamideProduct
CytarabineProduct
DexamethasoneProduct
DoxorubicinProduct
Leucovorin CalciumProduct
MercaptopurineProduct
MethotrexateProduct
PegaspargaseProduct
ThioguanineDrug
Vincristine